Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels. [electronic resource]
Producer: 20130124Description: 668-76 p. digitalISSN:- 1791-2431
- Animals
- Apoptosis -- genetics
- Cell Growth Processes -- genetics
- Cell Line, Tumor
- Chemokine CXCL10 -- biosynthesis
- Cystadenocarcinoma, Serous -- blood supply
- Female
- Genetic Therapy -- methods
- Heparin -- administration & dosage
- Human Umbilical Vein Endothelial Cells -- cytology
- Humans
- In Situ Nick-End Labeling
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Nanogels
- Neovascularization, Pathologic -- genetics
- Ovarian Neoplasms -- blood supply
- Plasmids -- administration & dosage
- Polyethylene Glycols -- administration & dosage
- Polyethyleneimine -- administration & dosage
- Transfection -- methods
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.